Merck Cuts 125 Employees Following R&D Center Closure in London
SOURCENews reportView the filing ↗
What we know
Location: London, UK.
Department affected: Research and Development.
Based on news reporting.
Summary
Merck & Co., Inc. has laid off 125 employees as part of its decision to abandon a $1.3 billion research and development center in London. This closure reflects the company's strategic shift and restructuring efforts within its operations. The layoffs are a direct consequence of the facility's closure, which is part of a broader trend in the pharmaceutical industry to optimize R&D investments. The affected employees were primarily involved in research and development activities at the London site. This move underscores Merck's ongoing adjustments in response to market demands and operational efficiencies.
Merck & Co., Inc. cut 125 jobs affecting its Research and Development team as of September 11, 2025.
That is roughly 0.2% of the 70,000 people Merck & Co., Inc. employs.
LayoffTalk has tracked 34 layoff events at Merck & Co., Inc. since May 2025, including 146 jobs documented in official WARN filings, with 31 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Merck & Co., Inc.
Recent tracked events at this company.